Dr. Jethro Ekuta Joins BP Logix Life Sciences Strategic Advisory Board

Global regulatory leader brings decades of experience to guide the next generation of medical affairs automation.

SAN DIEGO--(BUSINESS WIRE)--BP Logix, a leading provider of AI-enabled medical affairs automation technology, is proud to announce the appointment of Dr. Jethro Ekuta to its Life Sciences Strategic Advisory Board.

Dr. Ekuta is the Chair of the Board of Directors for the Regulatory Affairs Professionals Society (RAPS) and currently serves as Chief Regulatory & Safety Officer at Ascendis Pharma.

With over 30 years of experience in regulatory affairs and pharmacovigilance, Dr. Ekuta brings a deep understanding of global compliance, regulatory strategy and innovation in drug development. He has held senior leadership roles at organizations including Ascendis Pharma, Alexion (AstraZeneca Rare Disease), Horizon Therapeutics (Amgen), Johnson & Johnson, Genzyme (Sanofi), Bristol-Myers Squibb, Pfizer and the U.S. Food and Drug Administration (FDA).

“We are honored to welcome Dr. Ekuta to our Life Sciences Strategic Advisory Board,” said Girish Pashilkar, CEO of BP Logix. “His regulatory insight and leadership will be instrumental as we continue to expand our footprint in the life sciences sector and support teams navigating increasingly complex review and approval processes.”

“I’ve spent my career working to improve regulatory systems and processes within the pharmaceutical and biotech industries,” said Dr. Ekuta. “I believe BP Logix is uniquely positioned to help life sciences organizations streamline compliance, reduce risk and move faster without compromising integrity. I’m excited to contribute to the company’s mission and support its growth in this critical space.”

In his advisory role, Dr. Ekuta will provide strategic input across marketing, product, and customer engagement initiatives. His appointment is part of a broader effort by BP Logix to deepen its alignment with industry leaders and further tailor its solutions to the evolving needs of life sciences organizations.

About BP Logix

BP Logix helps medical affairs and regulatory teams at life sciences organizations streamline complex review and approval workflows. Its flagship solution, PubPro, simplifies the publication process, while the broader Approvia platform supports use cases such as MLR reviews, clearance systems, medical information requests and IIS evaluations. With a focus on configurability, compliance and speed, BP Logix empowers teams to reduce risk, improve collaboration and bring high-quality treatments to market faster.

To learn more about BP Logix and its work in life sciences, visit www.bplogix.com.